Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination

被引:42
作者
Ovsyannikova, IG
Jacobson, RM
Vierkant, RA
Pankratz, VS
Jacobsen, SJ
Poland, GA [1 ]
机构
[1] Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA
关键词
measles vaccine; humoral immunity; HLA genes;
D O I
10.1016/j.vaccine.2003.11.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Associations between human leukocyte antigen (HLA) genes and very high levels of antibodies (or hyperseroresponsiveness) to measles antigens in a genetically heterogeneous human population are poorly understood. We studied the association between antibody levels after measles vaccination and HLA class I and II alleles among 170 US schoolchildren who received one dose of measles-mumps-rubella 11 vaccine. Vaccine recipients were divided into two groups: 93 recipients who were seropositive and 77 recipients who were hyperseropositive (the upper 10th percentile of antibody levels of all subjects). Out of all the alleles analyzed, HLA-B*7 (odds ratio (OR) 1.9; P = 0.05), DQA1*0104 (OR 4.6; P = 0.02) and DPA1*0202 (OR 4.8; P = 0.04) alleles were positively associated with hyperseropositivity, whereas HLA-B*44 (OR 0.4; P = 0.02), DRB1*01 (OR 0.6; P = 0.09), DRB1*08 (OR 0.3; P = 0.04), DQB1*0301 (OR 0.5; P = 0.04), and DPB1*0401 (OR 0.6; P = 0.03) alleles were negatively associated with hyperseropositivity. The alleles B*44, DRB1*01, DRB1*08 and DQA1*0104 remained statistically significant after accounting for the effects of other alleles. The results suggest that HLA alleles have important associations with measles antibody hyperseropositivity. These data increase our understanding of measles vaccine-induced immune response and will be useful for future mechanistic work on measles virus antigen processing and presentation in seronegative and hyperseropositive individuals. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1914 / 1920
页数:7
相关论文
共 37 条
[1]   HLA-DPA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) and distribution of DPA1 alleles in Caucasian, African and Oriental populations [J].
AldenerCannava, A ;
Olerup, O .
TISSUE ANTIGENS, 1996, 48 (03) :153-160
[2]   GENETIC PREDICTION OF NONRESPONSE TO HEPATITIS-B VACCINE [J].
ALPER, CA ;
KRUSKALL, MS ;
MARCUSBAGLEY, D ;
CRAVEN, DE ;
KATZ, AJ ;
BRINK, SJ ;
DIENSTAG, JL ;
AWDEH, Z ;
YUNIS, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (11) :708-712
[3]  
BECK HP, 1995, AM J TROP MED HYG, V53, P284
[4]   ENZYME-LINKED IMMUNOSORBENT-ASSAY FOR DETECTION OF MEASLES ANTIBODY [J].
BOTELER, WL ;
LUIPERSBECK, PM ;
FUCCILLO, DA ;
OBEIRNE, AJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1983, 17 (05) :814-818
[5]   Frequency of HLA-DPB1 disparities detected by reference strand-mediated conformation analysis in HLA-A, -B, and-DRB1 matched siblings [J].
Büchler, T ;
Gallardo, D ;
Rodríguez-Luaces, M ;
Pujal, JM ;
Grañena, A .
HUMAN IMMUNOLOGY, 2002, 63 (02) :139-142
[6]   Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen [J].
Caillat-Zucman, S ;
Gimenez, JJ ;
Wambergue, F ;
Albouze, G ;
Lebkiri, B ;
Naret, C ;
Moynot, A ;
Jungers, P ;
Bach, JF .
KIDNEY INTERNATIONAL, 1998, 53 (06) :1626-1630
[7]  
Chang KM, 1999, J IMMUNOL, V162, P1156
[8]   EXTENT OF T-CELL RECEPTOR LIGATION CAN DETERMINE THE FUNCTIONAL-DIFFERENTIATION OF NAIVE CD4(+) T-CELLS [J].
CONSTANT, S ;
PFEIFFER, C ;
WOODARD, A ;
PASQUALINI, T ;
BOTTOMLY, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1591-1596
[9]   NONRESPONSIVENESS TO HEPATITIS-B VACCINE IN HEALTH-CARE WORKERS - RESULTS OF REVACCINATION AND GENETIC TYPINGS [J].
CRAVEN, DE ;
AWDEH, ZL ;
KUNCHES, LM ;
YUNIS, EJ ;
DIENSTAG, JL ;
WERNER, BG ;
POLK, BF ;
SNYDMAN, DR ;
PLATT, R ;
CRUMPACKER, CS ;
GRADY, GF ;
ALPER, CA .
ANNALS OF INTERNAL MEDICINE, 1986, 105 (03) :356-360
[10]   Measles elimination:: progress and challenges [J].
Cutts, FT ;
Henao-Restrepo, AM ;
Olivé, JM .
VACCINE, 1999, 17 :S47-S52